Triazoles as therapeutic agents for fungal infections
申请人:Synphar Laboratories, Inc.
公开号:US06153616A1
公开(公告)日:2000-11-28
A compound of formula I, or an optical isomer or pharmaceutically acceptable salt thereof, ##STR1## is disclosed as well as a pharmaceutical composition and a method of treating or preventing a fungal infection using the compound.
NEW TRIAZOLES AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS
申请人:Naeja Pharmaceutical Inc.
公开号:EP0889881B1
公开(公告)日:2003-04-23
1,2,4-Triazol-3-one antidepressants
申请人:Mead Johnson & Company
公开号:US04487773A1
公开(公告)日:1984-12-11
Phenoxyalkyl substituted-1,2,4-triazolones having anti-depressant properties typified by 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)- 2H-1,2,4-triazol-3(4H)-one are disclosed.
Described is a process for preparing triazolone compounds of the formula ##STR1## comprising heating a mixture of a compound of the formula ##STR2## and a hydrazine derivative of the formula R.sup.5 --NH--NH--CHO, R.sup.5 --NH--NH--C(O)OC(CH.sub.3).sub.3 or R.sup.5 --NH--NH--C(O)OCH.sub.2 C.sub.6 H.sub.5, optionally in the presence of an added base.